Dr Shafagh Waters

Scheme: Ideas Grants
Funding agency: National Health & Medical Research Council 
Grant name: Towards Personalised Cystic Fibrosis Medicine: Functional characterisation and targeted therapies for rare CF Transmembrane Regulator (CFTR) mutations using patient-derived organoids
Role: CIA, UNSW Grant number: RG191611 Start date: 1 January 2020

Scheme: 2019 Gene Therapy Innovation Grant
Funding agency: Cystic Fibrosis Community Care 
Grant name: Nanoparticle nanoparticle gene addition therapy in primary differentiated CF airway cell models.
Role: Sole CI, UNSW Grant number: RG194254 Start date: 1 January 2020

Scheme: Orphan Disease Center Million Dollar Bike Ride Grant Program
Funding agency: Penn Medicine Orphan Disease Centre | University of Adelaide  
Grant name: Airway Cell Therapy for Cystic Fibrosis Nonsense Mutations
Role: co-CI, UNSW Grant number: RG192792 Start date: 1 June 2019

Scheme: DAVID MILLAR GILES INNOVATION GRANT
Funding agency: CYSTIC FIBROSIS AUSTRALIA
Grant name: an australian alliance of personalised lab grown mini-organs to save the rarest of them all
Role: Sole CI, UNSW Grant number: RG191126 Start date: 1 August 2019
 

Scheme: TSANZ VERTEX PAEDIATRIC CYSTIC FIBROSIS AWARD
Funding agency: THORACIC SOCIETY OF AUSTRALIA AND NEW ZEALAND (TSANZ)
Grant name: a novel compound for cystic fibrosis therapy, targeting proteostasis network.
Role: Sole CI, UNSW Grant number: RG192793 Start date: 17 July 2019

Scheme: NSW HEALTH PAEDIATRIC PRECISION MEDICINE SHARED GRANT
Funding agency: PAEDIATRIO LIMITED
Grant name: ppm 1: centralized capacity to develop functional genomics for paediatric precision medicine
Role: CIB, UNSW Grant number: RG192369, Start date: 1 June 2019

Scheme: REBECCA L. COOPER MEDICAL PROJECT GRANTS
Funding agency: REBECCA L. COOPER MEDICAL RESEARCH FOUNDATION
Grant name: personalised lab grown mini-lungs to predict effect of therapies in patients with cystic fibrosis
Role: Sole CI, UNSW Grant number: RG182229, Start date: 1 January 2019

Scheme: CONTRACT RESEARCH
Funding agency: PAEDIATRIO LIMITED
Grant name: microscope funding for drug discovery and efficacy testing
Role: CIB, UNSW Grant number: RG182726, Start date: 24 October 2018

Scheme: VERTEX INNOVATION AWARDS
Funding agency: VERTEX PHARMACEUTICALS (CH)
Grant name: exo-cf; exosomal biomarkers for early prediction of cystic fibrosis related diabetes (cfrd)
Role: CIA, UNSW Grant number: RG181847, Start date: 22 March 2019

Scheme: ACFRT INNOVATION GRANT
Funding agency: CYSTIC FIBROSIS RESEARCH LIMITED QLD
Grant name: Rna therapeutics: novel paradigm in mutation independent cf therapy
Role: CIA, UNSW Grant number: RG173352, Start date: 5 March 2018

Scheme: BOOSTING BUSINESS INNOVATION PROGRAM
Funding agency: NSW DEPARTMENT OF INDUSTRY
Grant name: in vitro investigation of the potential efficacy of thiols to treat cystic fibrosis - techvoucher
Role: CIA, UNSW Grant number: RG161881-T Start date: 23 June 2018

Scheme: CONTRACT RESEARCH
Funding agency: BIOSPECIALTIES AUSTRALIA PTY LTD
Grant name: in vitro investigation of the potential efficacy of thiols to treat cystic fibrosis
Role: CIA, UNSW Grant number: RG181150, Start date: 4 June 2018